UCB (UCBJF)
(Delayed Data from OTC)
$165.75 USD
-3.04 (-1.80%)
Updated Aug 14, 2024 02:15 PM ET
1-Strong Buy of 5 1
C Value D Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (90 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.52 | 9.99 |
Current Quarter Estimate | NA | 0.39 | 61.00 |
Year Ago Quarter Estimate | NA | -0.79 | 54.84 |
Next Quarter Estimate | NA | -2.04 | 63.00 |
Next Year Estimate | 7.06 | 6.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.19 | 17.20 | 15.67 |
Next Year | 49.26 | 16.90 | 11.34 |
Last 5 Years | -4.10 | 7.00 | 8.10 |
Next 5 Years | NA | 22.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 3.34 | 1.47 |
Price/Cash Flow (MRFY) | 21.35 | 8.80 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -35.91% |
Return on Equity (TTM) | NA | -39.73% |
Debt to Equity (MRQ) | 0.33 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.